Pritha Bhadra

1.4k total citations · 1 hit paper
9 papers, 1.1k citations indexed

About

Pritha Bhadra is a scholar working on Pharmacology, Psychiatry and Mental health and Surgery. According to data from OpenAlex, Pritha Bhadra has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 4 papers in Psychiatry and Mental health and 2 papers in Surgery. Recurrent topics in Pritha Bhadra's work include Inflammatory mediators and NSAID effects (5 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers) and Musculoskeletal pain and rehabilitation (4 papers). Pritha Bhadra is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers) and Musculoskeletal pain and rehabilitation (4 papers). Pritha Bhadra collaborates with scholars based in United States, Israel and Netherlands. Pritha Bhadra's co-authors include Scott D. Solomon, Janet Wittes, Jan Hajer, Petr Dítě, María José Lechuga, Julius Špičák, Robert Fowler, Bernard Levin, Ann G. Zauber and I Rácz and has published in prestigious journals such as New England Journal of Medicine, Alimentary Pharmacology & Therapeutics and Journal of Pain.

In The Last Decade

Pritha Bhadra

9 papers receiving 1.0k citations

Hit Papers

Celecoxib for the Prevention of Colorectal Adenomatous Po... 2006 2026 2012 2019 2006 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pritha Bhadra United States 7 628 256 234 153 150 9 1.1k
Kouji Watanabe Japan 14 757 1.2× 190 0.7× 214 0.9× 464 3.0× 137 0.9× 51 1.3k
Susan Loftus United States 6 243 0.4× 147 0.6× 214 0.9× 89 0.6× 63 0.4× 10 579
Farhat V N Din United Kingdom 11 196 0.3× 275 1.1× 110 0.5× 87 0.6× 53 0.4× 28 935
Alan G. Meehan United States 21 212 0.3× 64 0.3× 311 1.3× 42 0.3× 126 0.8× 39 1.6k
Randall Harris United States 8 165 0.3× 314 1.2× 72 0.3× 291 1.9× 69 0.5× 9 769
M Fukushima Japan 18 324 0.5× 322 1.3× 150 0.6× 137 0.9× 12 0.1× 31 1.5k
E Fosslien United States 7 302 0.5× 83 0.3× 85 0.4× 132 0.9× 62 0.4× 11 682
Daniel Pelot United States 10 215 0.3× 211 0.8× 176 0.8× 97 0.6× 39 0.3× 14 900
Kenneth B. Pomerantz United States 19 194 0.3× 45 0.2× 261 1.1× 64 0.4× 178 1.2× 37 1.2k
Sven‐Christian Pawelzik Sweden 18 336 0.5× 72 0.3× 101 0.4× 165 1.1× 11 0.1× 26 954

Countries citing papers authored by Pritha Bhadra

Since Specialization
Citations

This map shows the geographic impact of Pritha Bhadra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pritha Bhadra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pritha Bhadra more than expected).

Fields of papers citing papers by Pritha Bhadra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pritha Bhadra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pritha Bhadra. The network helps show where Pritha Bhadra may publish in the future.

Co-authorship network of co-authors of Pritha Bhadra

This figure shows the co-authorship network connecting the top 25 collaborators of Pritha Bhadra. A scholar is included among the top collaborators of Pritha Bhadra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pritha Bhadra. Pritha Bhadra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Resnick, Malca, Pritha Bhadra, Verne Pitman, & Thomas Röth. (2013). Pregabalin improves fibromyalgia related sleep disturbance. Journal of Pain. 14(4). S61–S61. 1 indexed citations
3.
Bhadra, Pritha, et al.. (2012). Efficacy and Tolerability of Celecoxib versus Naproxen in Patients with Osteoarthritis of the Knee: A Randomized, Double-Blind, Double-Dummy Trial. Journal of International Medical Research. 40(4). 1357–1370. 23 indexed citations
4.
Strand, Vibeke, Lee S. Simon, Maxime Dougados, et al.. (2011). Treatment of Osteoarthritis with Continuous Versus Intermittent Celecoxib. The Journal of Rheumatology. 38(12). 2625–2634. 20 indexed citations
5.
Bhadra, Pritha & Danielle Petersel. (2010). Medical conditions in fibromyalgia patients and their relationship to pregabalin efficacy: pooled analysis of Phase III clinical trials. Expert Opinion on Pharmacotherapy. 11(17). 2805–2812. 9 indexed citations
6.
Petersel, Danielle & Pritha Bhadra. (2010). Neurological symptoms in fibromyalgia patients and their relationship to pregabalin efficacy: pooled analysis of phase 3 clinical trials. Journal of Pain. 11(4). S16–S16. 2 indexed citations
8.
Goldstein, Jay L., Glenn M. Eisen, B. S. Lewis, et al.. (2007). Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Alimentary Pharmacology & Therapeutics. 25(10). 1211–1222. 148 indexed citations
9.
Arber, Nadir, Craig Eagle, Julius Špičák, et al.. (2006). Celecoxib for the Prevention of Colorectal Adenomatous Polyps. New England Journal of Medicine. 355(9). 885–895. 751 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026